Ameriprise’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-48,656
Closed -$294K – 4145
2026
Q1
$294K Sell
48,656
-26,551
-35% -$155K ﹤0.01% 3764
2025
Q4
$538K Sell
75,207
-33,525
-31% -$238K ﹤0.01% 3596
2025
Q3
$821K Buy
+108,732
New +$794K ﹤0.01% 3448
2025
Q2
– Sell
-18,275
Closed -$57K – 4010
2025
Q1
$57K Sell
18,275
-343
-2% -$1.2K ﹤0.01% 3935
2024
Q4
$73.5K Buy
+18,618
New +$65.3K ﹤0.01% 3981

Other funds holding EVLV

Ameriprise's EVLV Position: Q2 2026 in Review

Ameriprise sold out of Evolv Technologies (EVLV) in Q2 2026, closing a stake of 48,656 shares — an estimated $294K sold.

Ameriprise first reported a position in EVLV in Q4 2024 and held it in 5 quarters. The position peaked at $821K in Q3 2025. 261 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

  • Ameriprise reported no remaining Evolv Technologies position as of Q2 2026 after selling out during the quarter.
  • Ameriprise sold 48,656 Evolv Technologies shares in Q2 2026, an estimated $294K.
  • Ameriprise first reported a position in Evolv Technologies in Q4 2024 and held it in 5 quarters.
  • Ameriprise's Evolv Technologies position peaked at $821K in Q3 2025.
  • 261 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.